Dec 31 • 15:44 UTC 🇪🇸 Spain El Mundo

The medicine cabinet for 2026: Ozempic's 'pill', multiple cancer therapies, and news in inflammatory pathologies

The article discusses the anticipated developments of leading drugs in 2026, focusing on GLP-1 agonists, new multi-target compounds, and advancements in treatments for obesity and diabetes, along with their expanding applications in other health conditions.

📡 Similar Coverage